Predictors of surgical approach for the management of renal cell carcinoma: a population-based study from New South Wales

被引:9
作者
Patel, Manish I. [1 ,2 ]
Strahan, Stephen [2 ]
Bang, Albert [3 ]
Vass, Justin [3 ,4 ]
Smith, David P. [3 ,5 ]
机构
[1] Univ Sydney, Sydney Med Sch, Discipline Surg, Sydney, NSW, Australia
[2] Westmead Hosp, Dept Urol, Sydney, NSW, Australia
[3] NSW Canc Council, Canc Res Div, Sydney, NSW, Australia
[4] Royal North Shore Hosp, Sydney, NSW, Australia
[5] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia
关键词
hospital volume; laparoscopy; partial nephrectomy; radical nephrectomy; renal cell carcinoma; PARTIAL NEPHRECTOMY; STAGE MIGRATION; TRENDS; CANCER; COHORT;
D O I
10.1111/ans.13653
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundThe simultaneous adoption of laparoscopy and partial nephrectomy (PN) has been reported to result in unintended consequences. We aim to examine the contemporary (2001-2009) trends in use of PN and laparoscopy within a population-wide database. MethodsAll renal cell carcinomas diagnosed between 2001 and 2009 in New South Wales, Australia, were identified from the Central Cancer Registry. Records of treatment were electronically linked. All patients with localized renal cell carcinoma who underwent surgical treatment were selected for this study (3771 patients). Follow-up was to the end of 2010. Multivariable logistic regression analysis was used to determine predictors of PN and laparoscopy. ResultsIn the entire cohort, 150 (4%), 495 (13%), 1516 (40%) and 1610 (43%) received laparoscopic PN, open PN, laparoscopic radical nephrectomy (RN) and open RN, respectively. Between the years 2001 and 2009, there was a gradual increase in the use of PN except between 2005 and 2007. Between 2001 and 2009, a rapid uptake of laparoscopy was observed. Multivariable analysis demonstrated that age (OR: 0.99 (0.98-0.99)), year of surgery (OR: 1.15 (1.11-1.19)), comorbidity (OR: 1.40 (1.12-1.76)) and hospital case load >8/year (OR: 2.39 (1.49-3.81)) predicted use of PN. Year of surgery (OR: 1.19 (1.15-1.21)), comorbidity (OR: 0.70 (0.58-0.85)), non-teaching hospital (OR: 0.70 (0.53-0.93)), private hospital (OR: 1.86 (1.45-2.38)) and hospital case load > 8/year (OR: 3.36 (2.22-5.09)) predicted use of laparoscopy. ConclusionThe unintended decrease in PN associated with increased use of laparoscopic RN had reversed by 2009. Hospital case load predicts the use of PN and laparoscopy.
引用
收藏
页码:E193 / E198
页数:6
相关论文
共 50 条
  • [41] Population-based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ
    Keymeulen, K. B. I. M.
    Geurts, S. M. E.
    Lobbes, M. B. I.
    Heuts, E. M.
    Duijm, L. E. M.
    Kooreman, L. F. S.
    Voogd, A. C.
    Tjan-Heijnen, V. C. G.
    BRITISH JOURNAL OF SURGERY, 2019, 106 (11) : 1488 - 1494
  • [42] Surgical management of hepato-pancreatic metastasis from renal cell carcinoma
    Chatzizacharias, Nikolaos A.
    Rosich-Medina, Anais
    Dajani, Khaled
    Harper, Simon
    Huguet, Emmanuel
    Liau, Siong S.
    Praseedom, Raaj K.
    Jah, Asif
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (02) : 70 - 77
  • [43] Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study
    Hofmann, J. N.
    Baccarelli, A.
    Schwartz, K.
    Davis, F. G.
    Ruterbusch, J. J.
    Hoxha, M.
    McCarthy, B. J.
    Savage, S. A.
    Wacholder, S.
    Rothman, N.
    Graubard, B. I.
    Colt, J. S.
    Chow, W-H
    Purdue, M. P.
    BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1772 - 1775
  • [44] A Simple-To-Use Nomogram for Predicting Early Death in Metastatic Renal Cell Carcinoma: A Population-Based Study
    Chen, Tao
    Zhan, Xiangpeng
    Du, Junfu
    Liu, Xiaoqiang
    Deng, Wen
    Zhao, Shuaishuai
    Jiang, Ming
    Xiong, Yunqiang
    Zhang, Xiaohai
    Chen, Luyao
    Fu, Bin
    FRONTIERS IN SURGERY, 2022, 9
  • [45] Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study
    Wang, Jinkui
    Zhanghuang, Chenghao
    Tan, Xiaojun
    Mi, Tao
    Liu, Jiayan
    Jin, Liming
    Li, Mujie
    Zhang, Zhaoxia
    He, Dawei
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [46] Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort
    Quoc-Dien Trinh
    Schmitges, Jan
    Bianchi, Marco
    Sun, Maxine
    Shariat, Shahrokh F.
    Sammon, Jesse
    Jeldres, Claudio
    Zorn, Kevin
    Sukumar, Shyam
    Perrotte, Paul
    Graefen, Markus
    Rogers, Craig G.
    Peabody, James O.
    Menon, Mani
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2012, 110 (2B) : E21 - E27
  • [47] Anatomical Distributions of Basal Cell Carcinoma and Squamous Cell Carcinoma in a Population-Based Study in Queensland, Australia
    Subramaniam, Padmini
    Olsen, Catherine M.
    Thompson, Bridie S.
    Whiteman, David C.
    Neale, Rachel E.
    JAMA DERMATOLOGY, 2017, 153 (02) : 175 - 182
  • [48] A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study
    Wang, Jinkui
    Tang, Jie
    Chen, Tiaoyao
    Yue, Song
    Fu, Wanting
    Xie, Zulong
    Liu, Xiaozhu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [49] The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study
    Deng, Ruiyi
    Qiu, Jianhui
    Shang, Jiaheng
    Yu, Chaojian
    Tian, Peidong
    Zhao, Zihou
    Cai, Lin
    Zhou, Jingcheng
    Gong, Kan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 25 (01)
  • [50] Prevalence of Germline Pathogenic Variants in Renal Cancer Predisposition Genes in a Population-Based Study of Renal Cell Carcinoma
    Bruinsma, Fiona
    Harraka, Philip
    Jordan, Susan
    Park, Daniel J.
    Pope, Bernard
    Steen, Jason
    Milne, Roger L.
    Giles, Graham G.
    Winship, Ingrid
    Tucker, Katherine M.
    Southey, Melissa C.
    Nguyen-Dumont, Tu
    CANCERS, 2024, 16 (17)